199657-29-9
199657-29-9
Chemical Structure
Givinostat hydrochloride
Synonym(s): ITF-2357 hydrochloride
- CAS No.: 199657-29-9
- Formula:C24H28ClN3O4
- Molecular Weight:457.95
IUPAC Name: (6-((diethylamino)methyl)naphthalen-2-yl)methyl (4-(hydroxycarbamoyl)phenyl)carbamate hydrochloride
InChIKey: QKSGNWJOQMSBEP-UHFFFAOYSA-N
SMILES: O=C(OCC1=CC=C2C=C(CN(CC)CC)C=CC2=C1)NC3=CC=C(C(NO)=O)C=C3.[H]Cl
Biological Activity: Givinostat (ITF-2357) hydrochloride is a HDAC inhibitor with an IC50 of 198 and 157 nM for HDAC1 and HDAC3, respectively. Givinostat hydrochloride can penetrate the blood-brain barrier (BBB).[1][2][3][4].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Givinostat hydrochloride | 98.63% | Givinostat (ITF-2357) hydrochloride is a HDAC inhibitor with an IC50 of 198 and 157 nM for HDAC1 and HDAC3, respectively. Givinostat hydrochloride can penetrate the blood-brain barrier (BBB).. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Givinostat hydrochloride (Standard) | ≥98% | Givinostat (hydrochloride) (Standard) is the analytical standard of Givinostat (hydrochloride). This product is intended for research and analytical applications. Givinostat (ITF-2357) hydrochloride is a HDAC inhibitor with an IC50 of 198 and 157 nM for HDAC1 and HDAC3, respectively. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Structural Analogs
-
Similarity Score 0.99
HY-14842BRGivinostat hydrochloride monohydrate (Standard) -
Similarity Score 0.99
HY-14842RGivinostat (Standard) -
Similarity Score 0.59
HY-147731HDAC6-IN-9 -
Similarity Score 0.56
HY-162060YPX-C-05 -
Similarity Score 0.56
HY-149418BChE/HDAC6-IN-2 -
Similarity Score 0.55
HY-157314HDAC6-IN-27 -
Similarity Score 0.55
HY-16699Nexturastat A -
Similarity Score 0.54
HY-23206DAN-1 EE hydrochloride -
Similarity Score 0.54
HY-12163Entinostat -
Explore the MedChemAI to find more analogs
References
- [1]. Li S, et al. Specific inhibition of histone deacetylase 8 reduces gene expression and production of proinflammatory cytokines in vitro and in vivo. J Biol Chem. 2015 Jan 23;290(4):2368-78. [Content Brief]
- [2]. Leoni F, et al. The histone deacetylase inhibitor ITF2357 reduces production of pro-inflammatory cytokines in vitro and systemic inflammation in vivo. Mol Med. 2005 Jan-Dec;11(1-12):1-15. [Content Brief]
- [3]. Wang YG, et al. Givinostat inhibition of hepatic stellate cell proliferation and protein acetylation. World J Gastroenterol. 2015 Jul 21;21(27):8326-39. [Content Brief]
- [4]. Taiarol L, et al. Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics. Cancers (Basel). 2022 Jun 16;14(12):2978. [Content Brief]
